In sum, these results highlight a potentially critical role for DSG2 based cell-cell adhesion in the progression of prostate carcinoma, and demonstrate that DSG2 may be a useful predictive biomarker of clinically significant prostate cancer. Here, DSG2 is linked to Familial prostate cancer.